Diabetes in renal dysfunction (kidney disease)
After completing this module, you should:
- Understand the rationale of selecting anti-diabetic agents for glycaemic control in patients with renal impairment
- Know about the concept of new-onset diabetes after transplant (NODAT) and its management.
Peer reviewed by:
|BMJ Learning||1 credit, 1:00 hour||BMJ Learning has assigned one hour of credit to this module|